Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Concetta Quintarelli

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|April 7, 2023
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumorsGiada Del Baldo, Francesca Del Bufalo, Claudia Pinacchio, et al.
Haematologica|November 11, 2003
Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutationsMarco Picardi, Fabrizio Pane, Concetta Quintarelli, et al.
Frontiers in Immunology|May 23, 2019
Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell KillingTiziano Ingegnere, Francesca Romana Mariotti, Andrea Pelosi, et al.
Frontiers in Immunology|February 15, 2021
Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell TransplantationGerrit Weber, Luisa Strocchio, Francesca Del Bufalo, et al.
Frontiers in Immunology|September 8, 2023
Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapyMaria Luigia Carbone, Alessia Capone, Marika Guercio, et al.
Molecular Oncology|September 18, 2021
PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanismLuca Simula, Ylenia Antonucci, Giorgia Scarpelli, et al.
Oncoimmunology|December 8, 2018
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patientsBelinda Palermo, Ornella Franzese, Cosmo Di Donna, et al.
NPJ Precision Oncology|August 20, 2025
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous systemAlba Clara Fernández-Rilo, Emmanuel de Billy, Giada Del Baldo, et al.
Blood|September 18, 2009
Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)Biagio De Angelis, Gianpietro Dotti, Concetta Quintarelli, et al.
Biomedicines|June 24, 2022
Clinical and Molecular Spectrum of Sporadic Vascular Malformations: A Single-Center StudyAndrea Diociaiuti, Roberta Rotunno, Elisa Pisaneschi, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|April 7, 2023
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumorsGiada Del Baldo, Francesca Del Bufalo, Claudia Pinacchio, et al.
Haematologica|November 11, 2003
Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutationsMarco Picardi, Fabrizio Pane, Concetta Quintarelli, et al.
Frontiers in Immunology|May 23, 2019
Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell KillingTiziano Ingegnere, Francesca Romana Mariotti, Andrea Pelosi, et al.
Frontiers in Immunology|February 15, 2021
Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell TransplantationGerrit Weber, Luisa Strocchio, Francesca Del Bufalo, et al.
Frontiers in Immunology|September 8, 2023
Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapyMaria Luigia Carbone, Alessia Capone, Marika Guercio, et al.
Molecular Oncology|September 18, 2021
PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanismLuca Simula, Ylenia Antonucci, Giorgia Scarpelli, et al.
Oncoimmunology|December 8, 2018
Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patientsBelinda Palermo, Ornella Franzese, Cosmo Di Donna, et al.
NPJ Precision Oncology|August 20, 2025
GD2: hopes and challenges for the treatment of pediatric patients with tumors of the central nervous systemAlba Clara Fernández-Rilo, Emmanuel de Billy, Giada Del Baldo, et al.
Blood|September 18, 2009
Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)Biagio De Angelis, Gianpietro Dotti, Concetta Quintarelli, et al.
Biomedicines|June 24, 2022
Clinical and Molecular Spectrum of Sporadic Vascular Malformations: A Single-Center StudyAndrea Diociaiuti, Roberta Rotunno, Elisa Pisaneschi, et al.
Pageof 9